An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Abstract
Oxidative stress has been linked with a variety of diseases, being involved in the debut and/or progress of several neurodegenerative disorders. This review intends to summarize some of the findings that correlate the overproduction of reactive oxygen species with the pathophysiology of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Oxidative stress was also noted to modify the inflammatory response. Even though oxidative stress and neuroinflammation are two totally different pathological events, they are linked and affect one another. Nonetheless, there are still several mechanisms that need to be understood regarding the onset and the progress of neurodegenerative diseases in order to develop efficient therapies. As antioxidants are a means to alter oxidative stress and slow down the symptoms of these neurodegenerative diseases, the most common antioxidants, enzymatic as well as non-enzymatic, have been mentioned in this paper as therapeutic options for the discussed disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Generally known reactive oxygen species (ROS). Adapted from [13].](https://figures.cochat.ai/paper-figures/9dc1d012e9e34e18822030ec89569bfb/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-1.jpg)
![Figure 2 Dopamine metabolism and ROS production. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/3cc9438ebe354aeab026d8ea3f0ad7cc/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-2.jpg)
![Figure 3 Schematic representation of alterations in dopamine, iron, and alfa-synuclein promoting oxidative stress in the substantia nigra pars compacta. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/79d7743213bd4acd8dc276da40dae43e/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-3.jpg)
![Figure 4 The model of motor nerve terminal dysregulation in ALS. (A) Healthy NMJ. (B) Pathological changes in NMJ during early stage of ALS. (C) Pathological changes in NMJ during late stage of ALS. Abbreviations: Ach—acetyl choline, MuSK—muscle-specific kinase, NMJ—neuromuscular junction, ROS—reactive oxygen species, TSC—terminal Schwann. Reprinted from an open-access source [34].](https://figures.cochat.ai/paper-figures/2e64b95026e34c5ab6b7ccd689373902/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-4.jpg)
![Figure 5 Representation of ROS-induced mitochondrial abnormalities in AD. Reprinted from an open-access source [9].](https://figures.cochat.ai/paper-figures/43a7b1a13867494ca7957071279194b2/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-5.jpg)
![Figure 6 Mutant HTT (mHTT)-induced mitochondria-mediated reactive oxygen species (ROS) accumulation. Adapted from [62].](https://figures.cochat.ai/paper-figures/b96903214a6042b4b49c7465333ed8f1/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-6.jpg)
![Figure 7 Overview of microglial functions in response to stress and AD pathology. Adapted from [71].](https://figures.cochat.ai/paper-figures/982c0e0a6c73429884ec1275432bb076/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within this context, ω3 are able to ameliorate oxidative stress and neuroinflammation, which may explain part of their beneficial effects on PD [457].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [457]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 4×
“In more detail, high oxygen consumption, low antioxidant levels, and low regenerative capacity were observed to induce oxidative damage susceptibility in brain tissues [7].”
BackgroundInfluentialOxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 1×
“Moreover, due to the lowering of estrogen levels during menopause and longer life expectancy, women are more likely to develop AD than men [42,43].”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 2×
“sible for learning and memory, which are affected in AD brains [48].”
BackgroundA blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · cited 1×
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundHardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · cited 9×
“dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) [13,15].”
BackgroundInfluential13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Cited by
Items 501–600 of 1,000
Borassus flabellifer: A Multipurpose Tree with Potential Applications
Mohaideen, N. S. M. H., & Srinivasan, H. (2024) · Current Pharmacology Reports · doi:10.1007/s40495-024-00365-z · Cited by 5
“…inflammation can fuel cancer progression, promote neurological deteriorating ailments such as Parkinson's and Alzheimer's, aggravate prolonged respiratory ailments such asCOPD and asthma, support conditions such as obesity, gastrointestinal disorders, skin allergies and eye diseases etc [36, 37].”
Yang, Y., Lu, S., Liang, Y., Tu, X., Zeng, X., Wang, L., Pan, D., Zhang, T., & Wu, Z. F. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105079 · Cited by 5
Fursa, G. A., Andretsova, S. S., Shishkina, V. S., Voronova, A. D., Karsuntseva, E. K., Chadin, A. V., Reshetov, I. V., Stepanova, O. V., & Chekhonin, V. P. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06218-5 · Cited by 5
“…cerebral proteins (α-synuclein, β-amyloid, τ, TDP-43, FUS, etc .) associated with their pathological aggregation in cells, as well as microglial inflammation, disruption of autophagy mechanisms, and other processes, which ultimately leads to the development of programmed cell death [1,3,4,42-44].”
Quintanilla, M. E., Morales, P., Santapau, D., Gallardo, J., Rebolledo, R., Riveras, G., Acuña, T., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312828 · Cited by 5
“Compelling evidence suggests that once established, oxidative stress and neuroinflammation constitute a self-perpetuating cycle [16, 18, 19], wherein oxidative stress triggers neuroinflammation, which in turn, leads to or further maintains oxidative stress.”
BackgroundSaad, M. A., Rastanawi, A. A., El-Sahar, A. E., & El-Bahy, A. A. Z. (2024) · Steroids · doi:10.1016/j.steroids.2024.109528 · Cited by 5
Taheri, M., Mehr, M. A., & Ghafouri, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-80102-0 · Cited by 5
Ligand-to-Metal Ratio Governs Radical-Scavenging Ability of Malate-Stabilised Ceria Nanoparticles
Filippova, A. D., Baranchikov, A. E., Teplonogova, M. A., Savintseva, I. V., Popov, A. L., & Ivanov, V. K. (2024) · Nanomaterials · doi:10.3390/nano14231908 · Cited by 5
“The disruption of redox homeostasis and the development of oxidative stress are considered to be among the causes of neurodegenerative [1–3], cardiovascular [4–6] and autoimmune [7,8] diseases.”
Vasegh, S., Saadati, H., Abedi, A., & Mostafalou, S. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.55 · Cited by 8
Ogunmiluyi, O. E., Naiho, A. O., Emojevwe, V. O., Oladele, T. S., Adebisi, K. A., Siyanbade, J. A., & Akinola, A. O. (2024) · Journal of Toxicology · doi:10.1155/jt/9317271 · Cited by 5
Arfeen, M., Dhaked, D. K., & Mani, V. (2025) · Molecules · doi:10.3390/molecules30020266 · Cited by 5
Molecular mechanism underlying stress response and adaptation
Yusuf, J. A., Akanbi, S. T., Olorunlowu, D. R., Opoola, E. K., Ogunlade, E. E., Kayode, E. A., Adejobi, E. O., Sulaiman, Y. O., Odemakinde, D. I., Aworeni, E. O., et al. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.01.005 · Cited by 8
Zhang, Q., Zhang, G., Ba, P., Wu, T., & Wang, G. (2025) · Sleep and Biological Rhythms · doi:10.1007/s41105-025-00582-z · Cited by 8
“Therefore, neuroinflammation and oxidative stress can mutually stimulate each other [43].”
Unveiling the Impacts of Cashew Nuts on Oxidative Stress in Rats: A Systematic Review
Júnior, R. R. D. S., Rodrigues, V. I. O., CARVALHO, C. F. M. D., Moura, M. M. B., Feitosa, D. D. M., Lima, E. K. F., de Andrade, A. M., Arrais, J. F. D. A., de Souza, L. N., Knackfuss, M. I., et al. (2025) · Antioxidants · doi:10.3390/antiox14040441 · Cited by 5
Lin, W., Huang, C., Tan, Z. J., Xu, H., Wei, W., & Wang, L. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.03.008 · Cited by 5
Aydın, D. Y., Wu, J. J., & Chen, J. (2025) · Biosensors · doi:10.3390/bios15050315 · Cited by 5
The silent saboteur: oxidative stress and the path to cognitive dysfunction
Garcia, T. F. M., Desio, J. A. F., de Souza, E. F., Henkes, S. F. C., Santos, L. S., Muenho, J. D. C., Gonçalves, C. L., & dos Santos, J. C. C. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2510175 · Cited by 5
Chaudhary, S., Rawat, S., Mathur, S., Perveen, A., Hafeez, A., Bilgrami, A. L., & Ashraf, G. M. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2520707 · Cited by 8
“Therapeutic medicines must reach the CNS; hence, it is vital to tailor suitable vectors that can bypass BBB [20,21].”
From Sea to Relief: The Therapeutic Potential of Marine Algal Antioxidants in Pain Alleviation
Belda-Antolí, M., Ros‐Bernal, F., & Mampel, J. V. (2025) · Marine Drugs · doi:10.3390/md23070270 · Cited by 7
“Oxidative stress is a critical etiological factor in numerous inflammatory and neurodegenerative diseases associated with chronic pain [18].”
Elmorsy, E. M., Doghaither, H. A. A., Al-Ghafari, A. B., Alyamani, S. A., Mohammed, Z. M. S., Ebrahim, N. A., Elshopakey, G. E., & Shabana, S. M. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04276-z · Cited by 5
Health Benefits of Phytosterols in the Management of Several Non‐Communicable Disorders
Aboutaleb, A. S., Mahdy, E. S., Khamies, S. M., Hal, D. M., El‐Dessouki, A. M., El‐Shiekh, R. A., Hassan, M., Elshazly, A. M., Salman, A., Sayed, G. A., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500983 · Cited by 6
“Furthermore, the absence of reliable biomarkers obstructs the potential for early identification of most of these disorders [144].”
Du, R., Zhu, Y., Chen, P., Li, M., Zhang, Y., & Huang, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1357070 · Cited by 5
Getachew, B., Csoka, A. B., Copeland, R., Manaye, K. F., & Tizabi, Y. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00631-2 · Cited by 5
Anti-Neuroinflammatory Eremophilane Sesquiterpenoids from Marine-Derived Fungus Phoma sp. DXH009
Yang, G., Qin, M., Chen, M., Shi, Y., Liu, S., Rao, Y., Huang, L., & Fu, Y. (2025) · Marine Drugs · doi:10.3390/md23030094 · Cited by 4
Wu, Z., Zhao, Y., Hao, S., An, M., Song, C., & Li, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01371 · Cited by 5
Unveiling Exosome Potential: Transforming Treatments for Neurodegeneration
Tiwari, A. K., Singh, B. K., Singh, G. K., Meena, J., Agrawal, A. K., Kumar, S., & Modi, G. P. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00096 · Cited by 6
Huang, W., Wu, X., Chang, S., Peng, X., & Xiao, L. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04475-y · Cited by 5
Suna, O., Wattanathorn, J., Muchimapura, S., Thukham-mee, W., Iamsaard, S., & Uabundit, N. (2025) · Life · doi:10.3390/life15081308 · Cited by 4
“The existence of brain disorders can exacerbate oxidative stress and lipid peroxidation, resulting in brain damage and dysfunction [12].”
Ginsenoside Rg1 mitigates the prolonged isoflurane anesthesia-induced neuroimmune disruptions
Meng, X., Gong, S., Jia, X., Zheng, A., Jia, M., Fu, T., & Wu, K. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120327 · Cited by 7
Ren, X., Huang, Q., Xie, Z., Liu, Z., Wei, J., Zheng, J., Li, Z., Wang, Z., Li, T., Chen, Z., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123654 · Cited by 4
Guo, C., Liu, W., Jiang, H., Zhang, H.-J., Guo, Y., & Xu, J. (2025) · Phytochemistry Letters · doi:10.1016/j.phytol.2025.103035 · Cited by 4
Duan, J., Duan, W., Pu, X., Ma, C., Huang, H., & Xu, Z. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117570 · Cited by 5
Protein misfolding and its dual role in neurodegeneration and cancer progression
Jamwal, R. S., Sharma, B., Minerva, Gupta, A., Misri, S., Shankaryan, R., Shah, R., & Kumar, R. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.001 · Cited by 5
Milisavljević, K. D., & Milanović, Ž. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128851 · Cited by 4
NRF2 activation by CDDO-Im regulates inflammatory and autophagy pathways in human microglial cells
Chu, C., Uruno, A., Suzuki, T., Taguchi, K., Baird, L., Katsuoka, F., & Yamamoto, M. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.046 · Cited by 5
Asadpour, S., Mazdeh, M., Karimi, J., Khodadadi, I., & Shafiee, G. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70076 · Cited by 6
“Excessive ROS and reactive nitrogen species (RNS) disrupt the blood–brain barrier (BBB), promote leukocyte infiltration, and exacerbate inflammatory and degenerative processes in the CNS [2, 10, 11].”
Gu, J.-Y., Kang, J.-Y., Lee, W.-Y., Hwang, S., Lee, J.-S., & Son, C. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2025.2600952 · Cited by 4
“…associated with increased production of oxidative stress markers, such as ROs and NO, which are known to contribute to neuronal injury and death [40–42]. consistent with our hypothesis, avarol significantly and dose-dependently reduced the levels of these oxidative indicators in lPs-stimulated…”
Xin, Q., Gao, Z., Guo, J., Wang, Y., Zhang, Z., Liu, Y., Yang, B., & Sun, J. (2025) · Medicine · doi:10.1097/md.0000000000044698 · Cited by 4
“[7] Clinical pre-research studies have shown that acupuncture has strong antioxidant and reactive oxygen capacity, which can continuously increase the activity of oxygen free radical scavenging enzymes, reduce the expression of lactate dehydrogenase and malondialdehyde, increase the level of…”
Liu, J., Zhao, X., Zhang, L., Zhou, H., Li, X., Zheng, G., Zhou, X., Peng, Y., & Zhang, J. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.139326 · Cited by 4
Alim, A., Baek, Y., Lee, M., & Paek, J. (2026) · Communications Engineering · doi:10.1038/s44172-025-00581-5 · Cited by 4
“Given the established role of ROS as key mediators of neuroin fl ammation 67,101,102 ,wefurtherexaminedwhetherthePD-associated α -syn PFFs also elicited in fl ammatory responses in the dopaminergic neuronal cells.”
Jazuli, I., Hing, G. B., Selvaratnam, L., Han, L. L., Alex, D., & Kumari, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105764 · Cited by 5
Arfeen, M., & Mani, V. (2024) · Molecules · doi:10.3390/molecules29225354 · Cited by 4
Xu, L., Zhang, T., Zhu, B., Tao, H., Liu, Y., Liu, X., Zhang, Y., & Meng, X. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101146 · Cited by 6
“Major NDDs, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), rank among the leading global causes of disability and mortality, particularly affecting aging populations [1].”
Nanotechnological advancement for the treatment of neurodegenerative disorders
Rai, G., Sharma, S., Singh, A., Chandekar, V., Rastogi, A., Gauba, P., Chaudhary, V., & Dang, S. (2024) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2024.2431086 · Cited by 5
Rlip76 in ageing and Alzheimer’s disease: Focus on oxidative stress and mitochondrial mechanisms
Bandaru, M., Sultana, O. F., Islam, M. A., Alvir, R. V., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102600 · Cited by 4
Targeting Neuroinflammation and Apoptosis: Cardamonin’s Cognitive Benefits in Alzheimer’s 5XFAD Mice
Smail, S. W. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04308-4 · Cited by 4
Sharma, H., Yang, H.-W., Sharma, N., & An, S. S. A. (2024) · Pharmaceuticals · doi:10.3390/ph18010002 · Cited by 4
“Exogenous and endogenous sources may cause an increase in cellular oxidative stress [2], enhancing the deposition of oligomeric amyloid beta (A β ), which in turn triggers tau hyperphosphorylation and the formation and build-up of neurofibrillary tangles (NFTs) in neurons [3].”
Seminal oxidative stress and recurrent pregnancy loss: a systematic review and meta-analysis
Câmara, F. E. A., Sobral, D. D. S., Neto, F. T. L., Esteves, S. C., & Cavalcante, M. B. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104873 · Cited by 4
The Effect of Astaxanthin on the Treatment of Neurological Diseases and Lesions
Moghadam, B. B., Shirian, S., & Mashaie, K. S. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.13.1.87 · Cited by 4
Kaur, J., Sharma, V., Khan, H., Singh, S., & Singh, T. G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149568 · Cited by 4
Bragais, E. K. B., Co, K. A., Enriquez, D. N., Labarda, A. L., Manongsong, R. E., & Bragais, E. K. B. (2025) · TAP CHI SINH HOC · doi:10.15625/2615-9023/21657 · Cited by 4
Mitigating effects of plasmalogens on age-related cognitive impairment
Yu, J., Su, J., Zhang, Y., Qiao, Z., Zhang, W., Bi, R., Shi, C., Xiong, W., Wang, F., Wang, R., et al. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106790 · Cited by 4
Liu, X., Li, Z., Wang, Z., Wang, K., Rong, X., Wang, Y., Yan, T., Shu, W., Liu, C., & Zhu, B. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108585 · Cited by 4
Liu, Y., Li, W., Li, Y., Zhao, T., Wang, Z., Zhao, Y., & Luo, D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120082 · Cited by 4
Cheng, X., Peng, T., Li, J., & Li, H. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108373 · Cited by 4
Resveratrol: Harnessing Nature's Potential for Chronic Pain Relief
Wu, H. Y., Wu, J., Gao, S., Liu, L., Dai, X., Song, W., Zhang, L.-Q., Liu, D.-Q., Tang, Y., Zhou, Y., et al. (2025) · Aging and Disease · doi:10.14336/ad.2025.0530 · Cited by 5
“The body possesses inherent mechanisms to counteract OS, primarily antioxidants [58].”
Ceramella, J., D’Amato, A., Procopio, F., Mariconda, A., Chavarria, D., Iacopetta, D., Ortuso, F., Longo, P., Borges, F., & Sinicropi, M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136116 · Cited by 4
The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases
Sharma, A., Khan, Z., Nath, R., & Dixit, R. (2025) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2025-0018 · Cited by 5
Chira, A., & Lorenzetti, S. (2025) · Antioxidants · doi:10.3390/antiox14070854 · Cited by 2
“These interconnected pathways— each detailed in preceding sections—collectively contribute to progressive neuronal loss in disorders such as Alzheimer’s and Parkinson’s diseases [99].”
Li, J., Yang, Z., Zhao, J., Jia, Y., Zhang, Y., Tian, Z., Pan, X., Ren, Y., Li, L., & Li, Z. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00398 · Cited by 4
Zeng, Y., Li, H., Zi, J., Hu, Y., Li, X., Cao, Q., Li, Y., Ran, Z., Wang, X., Cheng, G., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119999 · Cited by 4
Dong, G., Liu, Y., Liu, H., Qiao, C., Chen, X., & Wang, L. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin39656 · Cited by 5
Wang, L., Feng, L., Ning, B., Wang, Z., Dai, C., & Li, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s534706 · Cited by 4
Dyclonine relieves the Parkinson’s disease progression in rotenone-induced Drosophila model
Li, M., Luo, S., Li, Y., Li, Y., Ma, B., Liu, F., Wang, H., Guo, J., & Li, L. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114561 · Cited by 4
Tekutskaya, E. E., Ilchenko, G. P., Dorohova, A. A., Malyshko, V. V., Baryshev, M., & Dzhimak, S. S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810252 · Cited by 4
“Much of the discussion about the initiation of oxidative stress and the role of ROS and radicals resulting from the effects of magnetic fields is focused on DNA damage caused by radicals [20,22,23].”
BackgroundResultOxidative stress and neurodegenerative diseases: a bidirectional Mendelian randomization study
Yin, Z., Yang, Z., Liu, Y., Zhao, L., & Liang, F. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2352195 · Cited by 6
Aliaghaei, A., & Meftahi, G. H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111039 · Cited by 4
Antioxidant Activity of Planar Catechin Conjugated with Trolox
Shimizu, W., Shoji, Y., Ohkubo, K., Ito, H., Nakanishi, I., & Fukuhara, K. (2024) · Antioxidants · doi:10.3390/antiox13101165 · Cited by 4
Young, B. D., Williams, D. E., Bright, A. J., Peterson, A., Traylor‐Knowles, N., & Rosales, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-80479-y · Cited by 4
“Neurodegenerative diseases are characterized by processes such as misfolded proteins 90,91 , oxidative stress 92,93 , disruption of calcium homeostasis 94,95 , and mitochondrial dysfunction 96,97 .”
Oxidative stress in hydrocephalus: A new potential therapeutic target
Zhao, J., Tang, Z., Jiang, Y., Yang, Y., Liao, J., Su, Z., Usman, A. M., Chen, X., & Xiao, G. (2024) · Brain‐X · doi:10.1002/brx2.70008 · Cited by 4
Riccitelli, G. C., Gironi, R., Melli, G., & Kaelin‐Lang, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031205 · Cited by 5
“Furthermore, rTMS has been shown to mitigate neuroinflammation [42] and oxidative stress [43,44], both of which contribute to PD progression and cognitive decline [44].”
Psychological and physiological computing based on multi-dimensional foot information
Li, S., Yao, H., Peng, R., Ma, Y., Zhang, B., Zhao, Z., Zhang, J., Chen, S., Wu, S., & Shu, L. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-024-11087-5 · Cited by 5
A novel paracetamol derivative alleviates lipopolysaccharide-induced neuroinflammation
Králová, A., Montaser, A. B., Tampio, J., Adla, S. K., Jalkanen, A. J., Rysä, J., & Huttunen, K. M. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177409 · Cited by 5
Nicotinamide-Loaded Peptoid Nanotubes for Energy Regeneration in Acute Brain Injury
Du, H., Trinh, T. K. H., Brandon, O. C., Zheng, R., Wang, H., Corry, K. A., Wood, T. R., Chen, C., & Nance, E. A. (2026) · ACS Nano · doi:10.1021/acsnano.5c19897 · Cited by 4
Örs, H., Alimoğulları, E., Erdem, S. A., Elmazoğlu, Z., & Ceylan‐Isik, A. F. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70073 · Cited by 4
Li, Z., Song, X., & Song, J. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102521 · Cited by 5
Qü, Y., Xiong, W., Zhou, R., Song, N., & Qian, J. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13616 · Cited by 4
“…ampli‑ fied, worsening myocardial injury (11). although dex has been revealed to mitigate oxidative stress in normoglycemic conditions, to the best of our knowledge, it remains unclear whether this cardioprotective effect extends to myocardial cells exposed to high glucose (HG) levels (12,13).”
Pal, A., Bhardwaj, V., Goel, F., & Garg, V. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10840-5 · Cited by 5
Duan, Q., Su, W., Gu, X., Long, J., Jiang, Z., Yin, K., Cai, W., Cao, B., Chi, L., Gao, X., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70766 · Cited by 4
“…as AD, PD, ALS, and FTD), elevated levels of ROS and reactive nitrogen species (RNS) and alterations in the antioxidant defense system are common (Teleanu et al. 2022, Perluigi et al. 2024, Korczowska-Łącka et al. 2023, Beers et al. 2022, Dong-Chen et al. 2023, Trist et al. 2019, Keating et al.…”
Parikh, A., Cholavaram, A. S., Babu, A. K. C., Deepankumar, K., & Vijayan, M. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00368 · Cited by 4
“ROS overproduction overwhelms antioxidant defenses, resulting in oxidative damage, cellular dysfunction, and death in neurons with inherently low antioxidative capacity (Teleanu et al., 2022).”
Rabelo, F., Lemos, I. D. S., Toe, C. P. D., Casagrande, D. D., Freitas, M. L. S., Quadra, M. R., Lima, I. R., Generoso, J. S., Michels, M., Silveira, P. C. L., et al. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01193-8 · Cited by 5
“It is well known that microglia is essential for the inflammation in the brain and that its dysfunction can affect this process (Colonna and Butovsky 2017; Teleanu et al. 2022).”
BackgroundApryatin, S. A., Traktirov, D. S., Karpenko, M. N., Ivleva, I. S., Pestereva, N. S., Bolshakova, M. V., Трофимов, А. Н., Fesenko, Z. S., & Клименко, В. М. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25228 · Cited by 4
Huang, M., Sui, R., Zhang, L., Zhu, Y., Yuan, X., Jiang, H., & Mao, X. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01320-y · Cited by 4
“Protein and lipid oxidation are considered crucial factors in Alzheimer’s patients (Teleanu et al. 2022).”
Tare, H. L., Thube, U., Kachave, R. N., Wagh, V. D., & Udugade, B. V. (2023) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.13.4.05 · Cited by 4
Acetylcholine - Recent Advances and New Perspectives
Heinbockel, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106304 · Cited by 5
Tkaczenko, H., Tverdokhlib, O., Honcharenko, V., & Kurhaluk, N. (2024) · Ukrainian Journal of Natural Sciences · doi:10.32782/naturaljournal.7.2024.1 · Cited by 3
Aronowitz, D. I., Geoffrion, T. R., Piel, S., Morton, S. R., Starr, J. P., Melchior, R. W., Gaudio, H., Degani, R. E., Widmann, N. J., Weeks, M. K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105466 · Cited by 3
“When mitochondrial dysfunction reaches a critical point, cellular bioenergetic imbalance causes irreversible cellular injury, cell death, and propagates further neuroinflammatory cascades [7].”
BackgroundTrivedi, R., Sıngh, S., Singh, V. K., Yadav, S., Singh, A. C., Singh, A., Chaurasia, R. N., Kumar, A., & Kumar, D. (2024) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2024.10.001 · Cited by 4
Xu, W., Zhao, X., Wang, J., Guo, Y., Ren, Z., Cai, L., Wu, S.-B., & Zhou, M. (2024) · Medicine · doi:10.1097/md.0000000000040141 · Cited by 4
Kondeva-Burdina, M., Panayotova, D., Nedialkov, P. T., & Kokanova-Nedialkova, Z. K. (2025) · Molecules · doi:10.3390/molecules30051061 · Cited by 3
“…such as neuroinflammation, mitochondrial dysfunction, aging, and elevated levels of iron and calcium, as well as the degradation of dopamine [21]. by various non-motor symptoms, including sleep disturbances, depression, and fatigue by various non-motor symptoms, including sleep…”
Identification and verification of oxidative stress-related genes in the diagnosis of osteoporosis
Liu, Z., Yang, X., Wang, Z., Li, Q., Gu, H., Meng, Q., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-06118-2 · Cited by 3
Dolanbay, S. N. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf100 · Cited by 3
Neoxanthin: A Promising Medicinal and Nutritional Carotenoid
Zhao, J., Zhuang, G., & Zhang, J. (2025) · Marine Drugs · doi:10.3390/md23080317 · Cited by 3
“Oxidative stress is implicated in the pathogenesis of diverse disorders, including cancer, inflammatory and hyperpigmentation disorders, neurodegenerative diseases, diabetes, and cardiovascular diseases [115].”
Justen, C. E., Chitolina, A. B. D. M., Finamor, I., Pavanato, M. A., Maurente, M. M., Vieira, I. M., da Veiga, M. L., Saab, E., Tamiosso, R. T., & Baldissera, M. D. (2025) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2025.2538591 · Cited by 4
Rabbani, M. G., Alif, S. M., Zhou, Z., Ryan, J. L., & Karim, M. N. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf174 · Cited by 6
Volarević, V., Harrell, C. R., Fellabaum, C., Djonov, V., & Volarević, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167795 · Cited by 3
Ignjatijević, A., Anđić, T., Lješević, M., Nikolić, B., Ganić, T., Spasović, S., & Vuletić, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091134 · Cited by 8
Wu, S., Liu, W., & Changying, Z. (2025) · Neurological Research · doi:10.1080/01616412.2025.2559431 · Cited by 6
“Additionally, AD has been indicated to trigger severe neuroinflammation and oxidative stress damage [45,46].”
Baştan, İ., İRDEM, D. İ., Sel, T., Kartal, Y. K., ERGİN, S. H., & Tunç, A. S. (2025) · Kafkas Universitesi Veteriner Fakultesi Dergisi · doi:10.9775/kvfd.2025.34251 · Cited by 3
“Notably, increased activities of both SOD and catalase in CSF have been observed in patients with chronic neurodegenerative diseases [41,42] , bacterial meningitis [32] and malaria [43] .”
Kushawaha, S. K., Vashisht, K., Kumar, H., Ashawat, M. S., & Baldi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01981-x · Cited by 4
Huang, J., Wang, N., Huang, X., Huang, S., Xie, G., Zhang, J., & Li, Z. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115015 · Cited by 3
Metadata
- Authors
- Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
- National Institute for Laser Plasma and Radiation Physics (RO)
- Bucharest Emergency University Hospital (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- University of Bucharest (RO)
- Corresponding author
- Grumezescu, Alexandru Mihai
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 11
- Pages
- 5938
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9180653
- OpenAlex
- W4281569188
- Cited by
- 1,085
- References
- 105
- Citations by year
- 2026: 270 · 2025: 405 · 2024: 254 · 2023: 132 · 2022: 23
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oxidative stress, neuroinflammation, neurodegenerative diseases, reactive oxygen species, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, antioxidants, antioxidant enzymes, non-enzymatic antioxidants
- MeSH terms
- Neuroinflammatory Diseases, Antioxidants, Humans, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.